WebSep 16, 2024 · Biocon Biologics, a subsidiary of Biocon, on Thursday said it will offer around 15 per cent stake to Serum Institute Life Sciences at a post-money valuation of about USD 4.9 billion. WebBiocon Biologics Limited (BBL), a subsidiary of Biocon Ltd. and Serum Institute Life Sciences Private Limited (SILS) announced a strategic alliance on Thursday and BBL said it will offer around 15 ...
Biocon Biologics, Serum Institute Life Sciences enter strategic ...
WebSep 17, 2024 · Biocon Biologics (BBL) and Serum Institute Life Sciences (SILS) have entered an alliance to work together on developing and commercialising vaccines, biological drugs, and antibody therapies together. BBL will sell a 15 per cent stake to SILS at a post-money valuation of $4.9 billion for access to 100 million annual doses of vaccines, … WebDec 7, 2024 · Biocon’s foray into the vaccine segment through a strategic tie-up with the Serum Institute of India has added to the cheer. It will market 100 million vaccine doses annually for 15 years, to be ... greene county assessor maps
Is the street starting to warm up to Biocon? - Shares up nearly …
WebSep 18, 2024 · By Express News Service. BENGALURU: Two leading biotech players — Bengaluru-based Biocon Biologics Limited and Pune-based Serum Institute Life … WebMay 18, 2024 · Biocon Biologics to go for IPO in 18-24 months: Kiran Mazumdar-Shaw. The Competition Commission of India (CCI) has approved a proposed deal involving Serum Institute Life Sciences, Covidshield Technologies and Biocon Biologics. Once the deal is complete, Serum Institute Life Sciences Pvt Ltd will have about 15 per cent stake in … WebSep 17, 2024 · Biocon Biologics, a unit of drugmaker Biocon Ltd, said late on Thursday it would offer a stake of about 15% to Serum Institute Life Sciences for access to 100 million doses of vaccines annually for 15 years, including COVID-19 shots. The deal with the unit of Serum Institute of India (SII), the world's largest vaccine maker, will value Biocon ... flu down 98%